NCT04972292View on ClinicalTrials.gov

Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

May 28, 2024

Study Completion Date

May 30, 2024

Conditions
Pain
Interventions
DRUG

FDC of codeine 30 mg/dipyrone 500 mg

Group 1: receive one (1) experimental drug tablet (FCD of codeine 30mg/dipyrone 500mg) + one (1) Tylex® placebo.

DRUG

Tylex

Group 2: receive one (1) Tylex® tablet (codeine 30 mg/paracetamol 500 mg) + one (1) FDC placebo tablet

Trial Locations (2)

06696-000

Eurofarma Laboratórios S.A, Brasil

Eurofarma Laboratorios S.A, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY

NCT04972292 - Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction | Biotech Hunter | Biotech Hunter